CRISPR Therapeutics stock pops following disclosure of RFK Jr. investment

President-Elect Trump"s Nominees For Upcoming Administration Continue Meeting With Lawmakers On Capitol Hill

Kevin Dietsch/Getty Images News

  • An investment disclosure form provided by President Donald Trump’s nominee to be the next HHS Secretary, Robert F. Kennedy Jr., revealed he has investments in several stocks, including CRISPR Therapeutics (NASDAQ:CRSP).
  • The revelation caused the stock’s share price to spike 10% at

Leave a Reply

Your email address will not be published. Required fields are marked *